Cotinine prevents memory loss and diminishes Alzheimer's disease-like pathology
Alzheimer's disease (AD) affects millions of people around the world and currently there are no effective therapies. Cotinine, a metabolite of nicotine, has been shown to be neuroprotective, prevent memory loss and reduce amyloid-β (Aβ) plaque pathology in transgenic AD mice. The beneficial eff...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2015-05-01
|
Series: | Frontiers in Cellular Neuroscience |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/conf.fncel.2015.35.00021/full |